These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7051136)

  • 21. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiologic effects of diltiazem in canine myocardium, with special reference to conduction delay during ischemia.
    Peter T; Fujimoto T; Hamamoto H; McCullen A; Mandel WJ
    Am J Cardiol; 1982 Feb; 49(3):602-5. PubMed ID: 7058768
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcium entry blockers: a review.
    Goad DL
    J Vet Pharmacol Ther; 1982 Dec; 5(4):233-9. PubMed ID: 6306265
    [No Abstract]   [Full Text] [Related]  

  • 24. Calcium channel blocking drugs.
    Johnston WE; Lowenstein E
    Contemp Anesth Pract; 1983; 7():163-91. PubMed ID: 6309475
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.
    Leon MB; Rosing DR; Bonow RO; Epstein SE
    Am J Cardiol; 1985 Jan; 55(3):69B-80B. PubMed ID: 2857518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared.
    Nakaya H; Schwartz A; Millard RW
    Circ Res; 1983 Mar; 52(3):302-11. PubMed ID: 6825222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium antagonists.
    Nayler WG
    Eur Heart J; 1980 Jun; 1(3):225-37. PubMed ID: 7285980
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
    Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of calcium antagonists on isolated myocardial tissue and their molecular mechanism of action].
    Bayer R; Kaufmann R; Rodenkirchen R; Mannhold R
    Herz; 1982 Aug; 7(4):203-10. PubMed ID: 6127299
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts.
    Orito K; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium ions, drug action and the heart--with special reference to calcium antagonist drugs.
    Opie LH
    Pharmacol Ther; 1984; 25(3):271-95. PubMed ID: 6151199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cardiovascular effects of a new calcium channel blocker AH-1058 with those of verapamil assessed in blood-perfused canine heart preparations.
    Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
    J Cardiovasc Pharmacol; 2000 May; 35(5):741-8. PubMed ID: 10813376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electropharmacological effects of a new dihydropyridine analog on isolated guinea pig papillary muscles and Purkinje fibers.
    Molyvdas PA; Sperelakis N
    J Cardiovasc Pharmacol; 1986; 8(3):449-58. PubMed ID: 2425157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The prolonged use of calcium antagonists in myocardial infarct in rats: their effect on hemodynamics and the contractile function and morphology of the heart muscle].
    Kazanova GV; Tsorin IB; Chichkanov GG; Zakharov SP; Shchegolev AI; Iavorskiĭ AN; Liubimov BI
    Eksp Klin Farmakol; 1992; 55(3):17-20. PubMed ID: 1458153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and nicardipine.
    Motomura S; Hashimoto K
    Jpn J Pharmacol; 1990 Feb; 52(2):319-30. PubMed ID: 2313939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
    Takahashi K; Taira N
    Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiological actions of calcium antagonists in the heart.
    Seipel L; Breithardt G
    Cardiology; 1982; 69 Suppl():105-16. PubMed ID: 7151071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of verapamil, diltiazem, and nifedipine on hemodynamics and left ventricular function during acute myocardial ischemia in dogs.
    Urquhart J; Patterson RE; Bacharach SL; Green MV; Speir EH; Aamodt R; Epstein SE
    Circulation; 1984 Feb; 69(2):382-90. PubMed ID: 6690104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of calcium antagonists in ventricular dysfunction.
    Josephson MA; Singh BN
    Am J Cardiol; 1985 Jan; 55(3):81B-88B. PubMed ID: 3881919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of several calcium antagonistic drugs (slow-channel blockers) on the electrical and mechanical activities of guinea pig papillary muscle.
    Molyvdas PA; Sperelakis N
    J Cardiovasc Pharmacol; 1983; 5(1):162-9. PubMed ID: 6186853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.